Largest Study to Date of Lebrikizumab Supports Its Use for Treatment of Atopic Dermatitis
Two phase 3 trials suggest that a 16 week treatment with a drug called lebrikizumab was effective in adults and adolescents with moderate to severe dermatitis, according to a paper published in the...
